21 reports

The drug candidate acts by targeting pollen allergen Bet v ##.

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Therapy
  • Anergis SA
  • ALLERGEN FOR PEANUT ALLERGY - DRUG PROFILE
  • ALLERGEN FOR PEANUT ALLERGY - DRUG PROFILE

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Chemotherapy
  • Therapy
  • Aimmune Therapeutics, Inc.
  • Vaccine for Grass Pollen Allergy - Drug Profile

Vaccine ## for Grass Pollen Allergy - Drug Profile Vaccine for Grass Pollen Allergy - Drug Profile Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Vaccine for Grass Pollen Allergy DC##U B

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Product Initiative

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Product Initiative

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Therapy
  • Biomay AG
  • SHORT RAGWEED POLLEN (AMBROSIA ARTEMISIIFOLIA) ALLERGEN EXTRACT ODT - DRUG PROFILE

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • United States
  • Product Initiative
  • ALLERGEN FOR PEANUT ALLERGY - DRUG PROFILE
  • R&D Progress

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • United States
  • Product Initiative
  • Aimmune Therapeutics, Inc.

HOUSE DUST MITE ALLERGY - PIPELINE BY STALLERGENES GREER PLC, H## 2019 House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUST MITE ALLERGY - DRUG PROFILE AM-## -

  • Allergy Immunotherapy
  • HIV AIDS
  • Medical Biotechnology
  • World
  • Product Initiative
  • AM-101 - DRUG PROFILE

" House dust mite allergy is one of the most common allergies, impacting the quality of life for patients across ages and geographies.

  • Allergy Immunotherapy
  • HIV AIDS
  • Medical Biotechnology
  • World
  • Product Initiative

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy Drug
  • Allergy Immunotherapy
  • Ophthalmic Solution
  • Pharmaceutical
  • Product Initiative

Drug Allergy- The allergy from medicines, drugs is the most common form of allergy.

  • Allergy Immunotherapy
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc

The hypersensitivity of the body to sun rays causes sun allergy. ##. ## Types of Allergy by Allergens Drug Allergy-The allergy from medicines, drugs is the most common form of allergy.

  • Allergy
  • Allergy Immunotherapy
  • World
  • Market Size
  • Allergy Therapeutics plc

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy Drug
  • Allergy Immunotherapy
  • Ophthalmic Solution
  • Pharmaceutical
  • Allergy Therapeutics plc

Hoffmann-La Roche Ltd ## ## ## ## ## AnaptysBio Inc ## ## ## ## ## Food Allergy Research & Education Inc ## ## ## ## ## Novartis AG ## ## ## ## ## Droege International Group AG ## ## ## ## ## Allertein Therapeutics LLC ## ## ## ## ## Allergy Therapeutics

  • Allergy Immunotherapy
  • Chemotherapy
  • Pharmaceutical
  • World
  • Aimmune Therapeutics, Inc.
  • Jun 06, 2017: Allergy Therapeutics: Directorate changes

He has previously spent over six years working at the US Food and Drug Administration (FDA) as a Medical Officer and Medical Team Leader in the Division of Pulmonary-Allergy Drug Products.

  • Allergy Immunotherapy
  • Europe
  • United States
  • Company Financials
  • Allergy Therapeutics plc

Food and Drug Administration (FDA).

  • Allergy
  • Allergy Immunotherapy
  • Therapy
  • United States
  • Aimmune Therapeutics, Inc.
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Helsinn Group
  • DEXAMETHASONE - DRUG PROFILE
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Helsinn Group

ALLERGIES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS ALLERGIES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* ALLERGIES THERAPEUTICS CLINICAL TR

  • Allergy
  • Allergy Immunotherapy
  • Chemotherapy
  • HIV AIDS
  • World

THE DRUG CANDIDATE IS A MUTANT DERIVATIVE BIRCH POLLEN ALLERGEN BET V ##.

  • Allergy Drug
  • Allergy Immunotherapy
  • HIV AIDS
  • Respiratory Disease
  • Product Initiative

RESULTS WERE PUBLISHED IN THE INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY.

  • Allergy Immunotherapy
  • Anesthetics
  • Chemotherapy
  • HIV AIDS
  • Opiant Pharmaceuticals, Inc.